Teva Reports First Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Teva Pharma (TEVA) CEO says they have no plans to issue equity to reduce debt
May 3, 2018 8:32 AM EDTOn call, Teva Pharma (NYSE: TEVA) CEO says they have no plans to issue equity to reduce debt
Teva Pharma (TEVA) Tops Q1 EPS by 28c, Raises FY Guidance
May 3, 2018 7:02 AM EDTTeva Pharma (NYSE: TEVA) reported Q1 EPS of $0.94, $0.28 better than the analyst estimate of $0.66. Revenue for the quarter came in at $5.1 billion versus the consensus estimate of $4.8 billion.
GUIDANCE:
Teva Pharma sees FY2018 EPS of $2.40-$2.65, versus the consensus... More
